type here...

CATEGORIES

Healthcare

LATEST

1...678...76Page 7 of 76

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Qatar Genome Research Consortium Reports First and Largest Comprehensive Genetic Association Study in Middle East

Medika Life -
A group of researchers at Qatar Foundation have reported the first and largest genetic association study in the Middle East, that has been published online in Nature Communications

When Immunity Goes Rogue

Michael Hunter, MD -
Do you have an autoimmune condition? There are some steps you can take to fight back.

A Virus May Cause Multiple Sclerosis

Michael Hunter, MD -
HARVARD RESEARCHERS MAY HAVE discovered the cause of multiple sclerosis (MS). This progressive disease affects 2.8 million individuals worldwide, and there is no cure. In the...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories